| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Worldwide R&D | EVP, Chief Medical Officer
1 company
Fuchs Henry J is a President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $10.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2018 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 31,000 | $90.00 | $2,790,084.79 | -3.8% | |
| Apr 2, 2018 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 10,000 | $80.12 | $801,200.00 | -3.1% | |
| Jan 2, 2018 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 15,000 | $89.23 | $1,338,400.50 | -10.1% | |
| Sep 15, 2017 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 15,000 | $90.50 | $1,357,500.00 | -9.9% | |
| Jun 19, 2017 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 15,000 | $90.00 | $1,350,000.00 | -3.5% | |
| Feb 24, 2017 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 15,000 | $87.99 | $1,319,850.00 | -10.5% | |
| Nov 25, 2016 | BMRN Biomarin Pharmaceutical Inc | President, Worldwide R&D | Sale+OE | 15,000 | $87.40 | $1,310,988.00 | -11.6% | |
| Aug 26, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Medical Officer | Sale+OE | 15,000 | $95.06 | $1,425,924.00 | -11.6% | |
| May 26, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Medical Officer | Sale+OE | 15,000 | $87.81 | $1,317,100.00 | -6.0% |